INSTITUTION     RESEARCH     DONATIONS     PRESS ROOM    


PRESS RELEASES

Find news and press releases on SHRO discoveries, events, and other significant announcements.




 

PRESS RELEASES: 2010 - 2005

SHRO RELEASE 2010

Provenge Approved for Advanced Prostate Cancer

May 30, 2010

The U.S. Food and Drug Administration has approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.


Understanding the Pathways to Cancer

May 30, 2010

The complex mechanisms and pathways behind genetic and epigenetic changes underpin the work of Marcella Macaluso, Ph.D., a research associate professor and Director of the Genetics & Epigenetics Program at the Sbarro Health Research Organization Center for Biotechnology


Sbarro Institute Joins Conference on HPV

May 25, 2010

Naples conference to discuss prevention of HPV-related diseases


Understanding Fat

April 27, 2010

Eva Surmacz, Ph.D., associate professor in Biology at Temple University and the Director of the Obesity and Cancer Program at SHRO studies how the cytokine leptin can cause cancer and interfere with anti-cancer therapies.


Study: High fat Diet  Ups Strokes in Postmenopausal Women

April 27, 2010

Post-menopausal women who consume the most daily dietary fat had a 40 percent higher incidence of strokes compared with women who ate the least amount, according to research presented at the American Stroke Association International Stroke Conference 2010.


New Pyrimidine Compounds May Lead to Improved Treatments for Childhood Brain Cancer

April 7, 2010

Src represents one of the most promising targets for cancer therapy. A new study by researchers from the Sbarro Health Research Center for Biotechnology  and the Human Health Foundation (www.hhfonlus.org), shows that pyrazolo-[3,4-d]–pyrimidine-derivatives, designed to target Src, may be effective in interfering with the cell cycle and causing cancer cell death in medulloblastoma, a childhood brain cancer. The results were published in FASEB (The Journal of the Federation of American Societies for Experimental Biology).

FASEB (abstract)

Eureka Alert

Newswise

Let's Combat Pain

March 22, 2010

New online forum puts pain treatment in the spotlight.


Novel Researcher: Luca D'Agostino

March 22, 2010

Investigating Novel Structure Proteins (NSPs) to  locate new targets for cancer therapies


Cutting Gravity May Speed Healing

February 18, 2010

Altering gravitational forces may speed the growth and repair of tissues at the cellular level, according to research completed by Andrew Puca, Ph.D., of the Sbarro Health Research Organization Center for Biotechnology Research.


Can Virtual Reality Help You to Shed Pounds?

February 17, 2010

A new study funded by the College of Health Professions and Social Work Interdisciplinary Research Fund at Temple University will pair the biotechnology skills of Dr. Giuseppe Russo, a research assistant professor and director of e-Health and Cancer Systems Biology programs at the Sbarro Health Research Organization Center for Biotechnology Research in the College of Science & Technology and the weight loss expertise of Dr. Melissa Napolitano, an associate professor at the Center for Obesity Research and Education (CORE) and Departments of Kinesiology and Public Health to find out.


Chronic Dry Eyes Can Be Helped

February 5, 2010

Dr. Mina Massaro-Giordano, an associate professor at the University of Pennsylvania and co-director of the Penn Dry Eye & Ocular Center, explains the problem of dry eyes and the newest therapies..

NBC Video

Why do Stem Cells Age? New study sheds light on senescence process

January 22, 2010

Researchers from the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the Human Health Foundation in Spoleto, Italy have found that MECP2, a gene that modifies the chromatin in the cell, has important role in stem cell aging.

PubMed

Changes in tumor suppressor gene suggest a heritable susceptibility to retinoblastoma

January 20, 2010

Researchers working at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy, have found that the downregulation, or reduction, of the tumor suppressor gene 16INK4A may be a novel marker of the heritable susceptibility for the disease.  The study  appears in the  Journal of Cellular Physiology.

Medical News Today

January is Glaucoma Awareness Month: Have You Scheduled an Eye Exam?

January 20, 2010

Glaucoma, a group of eye diseases that damage the optic nerve and destroy eyesight, affects close to four million Americans, although half are not aware that they have it. Worldwide, the World Health Organization reports that glaucoma is the primary cause of blindness for about 4.5 million people With its painless and gradual loss of vision, glaucoma may have no early warning signs, but it can be detected during a comprehensive dilated eye exam.

SHRO RELEASE 2009

Tracking the H1NI Pandemic in Italy

November 20, 2009

According to the Italian news agency ANSA, as of November 19th, 75 Italians have died from H1N1, with 28 from the Campania region of Naples.Giulio Tarro, M.D., the Chief Physician of Virology at Cotugno Hospital of Naples and an adjunct professor at Temple University of Philadelphia  discusses the impact, treatment and future of the flu  epidemic.

SHRO Research on Stem Cells Recognized

November 20, 2009

Research by Umberto Galderisi and Antonio Giordano on the effect of stem cells in the treatment of arterial stenosis will be published as part of the proceedings of the prestigious 5th International Conference on Mesenchymal and Non-Hematopoietic Stem Cells (MSCs) at Texas A & M Health Science Center College of Medicine.

 

Antonio Giordano Receives Dean's Distinguished Award for Excellence in Research

November 15, 2009
Antonio Giordano, the President of the Sbarro Health Research Organization, Inc., the Director of the Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology has won the Dean's Distinguished Award for Excellence in Research.

The award cites the quality of his work, "attested to by the fact that it provides an impetus for other investigators studying cancer growth control and it has resulted in a framework for our conceptualization of cancer development and mechanisms of tumor suppression."

 

Ang Sun, Ph.D. Wins Prize for 'Outstanding Research'

November 3, 2009

Dr. Ang Sun, who studied for six years for his Ph.D. under the guidance of Antonio Giordano, M.D., Ph.D., the Founder and President of the Sbarro Health Research Organization, has been awarded the 2009 Award for Outstanding Research by a Graduate Student from the College of Science and Technology at Temple University.

Sbarro Health Research Organization Welcomes New Biotech Research Center

October 27, 2009

The Sbarro Health Research Organization, a nonprofit research facility located at Temple University, dedicated a new state-of-the-art biotechnology research center on October 27th. SHRO has been ranked as one of the top three international laboratories based on number of publications as ranked by the Cell Cycle Registry.

Newswise
Temple Times online
Philadelphia Business Journal

 

Dedication Planned for New SHRO Biotechnology Research Center

October 18, 2009

The Sbarro Health Research Organization,will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m.

A host of dignitaries will join guests and researchers at the dedication ceremony, including Pennsylvania Representatives the Honorable Sam Smith and Mario J. Civera , Jr.  Also in attendance will be His  Eminence Cardinal Justin Rigali, Archbishop of Philadelphia, Ann Weaver Hart, the President of Temple University, and Hai-Lung Dai, Ph.D., the Dean of Temple University’s College of Science and Technology.

Cold Spring Harbor Laboratory  Celebrates Another Nobel Laureate

October 5, 2009

CSHL graduate Antonio Giordano remembers Carol Greider, 2009 Nobel Prize Winner in Medicine.

IGN

"National Mesothelioma Awareness Day" Introduced in Congress

October 2, 2009

Few Americans know the truth about mesothelioma, a deadly and incurable cancer cauesd by exposure to asbestos. Heavy and widespread use of asbestos through most of the last century, coupled with a 20-50 year latency in tumor development, make mesothelioma today a lethal threat to tens of millions of Americans. Yet, the U.S. has ignored the need for research to develop effective treaments, and   still has not even banned asbestos.

Antonio Giordano and SHRO Model Profiled in  Canadian Newspaper: Corriere Canadese

September 27, 2009

Antonio Giordano Wins Philip Mazzei 'The Bridge ' Award

September 24, 2009

President and Founder of SHRO  receives the prestigious   prize from The American University of Rome, in  recognition of his work to promote economic and scientific cooperation between Italy and the United States.

 

Sponsor-A-Scientist!

August 28, 2009

Bidding starts at $25,000  (it's tax-deductible!) to get Your Name (or  your loved one's or your company's) on  a   fellowship to be   awarded by the Philadelphia and Siena Italy-based Sbarro Health Research Organization.  Place your bid on E-Bay by clickin here !

Philly.com

Nature.com

Summer Brings High School Interns to the Sbarro  Institute

August 18, 2009

If it is summer in the city, that means that high school interns are hard at work in the Sbarro Institute laboratories located at Temple University in Philadelphia. This year, the Institute hosted three high school juniors, who worked closely with Sbarro Institute post-doctorate fellows Marco Cassone, M.D., Ph.D. and Valentina Caracciolo, Ph.D. and Annalisa Roberti, a Ph.D student.

Antonio Giordano, M.D., Ph.D.: A War We Must Win
August 11, 2009
In an impassioned Op-ed that appeared in the August 5th edition of the New York Times, Nobel Laureate James Watson called for a second "war on cancer" to finance and ease the regulatory path towards the development of new cancer drugs. Antonio Giordano, the President and Founder of S.H.R.O, writes that we must support Watson's call.

Neuronal Guidance Molecule May Lead to Future Treatments for Human Embryonal Carcinoma
August 1, 2009
A new finding shows that Netrin-1, a neuronal guidance molecule, may play a critical role in reducing the aggressiveness of human embryonal carcinoma (EC) cells. Results of the study appear in the journal Cancer Research.

Students Visit SHROs Digilab:
July 15, 2009
Researchers around Temple University’s Campus have welcomed BITS participants into their research centers, study zones, and smart classrooms as part of a six-week summer intensive program to learn sophisticated information and communication technology skills and applications. Next week, BITS students will visit the Digilab, a center for using virtual realities to support e-health research.

Cell Cycle Kinases as Therapeutic Targets for Cancer:
July 3, 2009
A featured article in the July 2009 online issue of Nature Reviews/Drug Discovery written by Antonio Giordano, M.D., Ph.D.,  DIrector of the Sbarro Institute for Cancer Research and Molecular Medicine, Director of the Center for Biotechnology at Temple University in Philadelphia, PA and ‘Chiara fama’ Professor in the Department of Pathology & Oncology at the University of Siena in Siena, Italy and Silvia Lapenna, Ph.D., a member of CROM (Center for Oncology Research) in Mercogliano, Italy, forecasts that "novel compunds with increased potency, improved kinase specificity and favorable drug like properties will soon be available for clinical  evaluation."
Medical News Today

Antonio Giordano, M.D., Ph.D. Places Third on  List of "Laboratory Heads by Number of Publications"
Cell Cycle Registry: July 2, 2009

 

Rate of Breast Cancer in Italy Significantly Higher  Than Previously Reported: June 29, 2009
A new analysis of breast cancer in Italy  from 2000 to 2005 shows a 72 percent spike above official estimates issued by the Ministry of Health, with the sharpest uptick  of +28.6 percent found in the youngest group studied (ages 25 to 44). Results from the Sbarro Health Research Organization, the CROM (Centro Richerhe Oncologiche Mercogliano) in Mercogliano, Italy, and the Human Health Foundation appear in The Journal of Experimental & Clinical Cancer Research.
Breast Cancer News (access by subscription only)

Italy Welcomes New Public Health TV Channel
On February 1st, Italian television introduced a new channel devoted to wellness, disease prevention, and nutrition. Salute!, which appears on Sky Television, is the first channel of its kind in Italy.

Researchers Locate Two New Potential Targets for Pediatric Tumor Treatments
A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation, the Sbarro Institute for Cancer Research and Molecular Medicine, report in Stem Cells and Development. The study represents a joint international effort between the Sbarro Health Research Organization, in Philadelphia, PA, Che University of Siena, in Siena, Italy and Bambin Gesu' in Rome, Italy.

Gene Marker May Improve Odds on Stem Cell Therapies for Disease
Researchers have tagged two new potential targets for treating rhabdomyosarcoma (RMS) -- a highly malignant pediatric tumor thought to arise from mesenchymal stem cells (MSCs) committed to become skeletal muscle cells. The report appears in Cell Cycle.

With an Eye To Italy
Sbarro Health Research Organization President, Antonio Giordano, M.D., featured in Philadelphia Inquirer: With an Eye to Italy: Research scientist builds lab and lures fine minds from home.


SHRO RELEASE 2008

International Conference Hosts Digi S Lab

Sbarro Health Research Organization researcher Dr. Letizia Cito of the CROM Institute, Mercogliano (AV, Italy) delivered a virtual lecture on "Cancer, Cell Cycle, and Check Points" as an invited guest to a scientific meeting sponsored by the University of Barcelona, Spain. Dr. Cito's lecture took place on The Learning Experience Main Campus in Second Life. View the lectures: Part-1 Part-2

Discovery of Small Molecule Leads to New Hope for HIV Therapy

New hope for combating HIV, the virus that leads to AIDS. The Laboratory of Pharmaceutical Chemistry, University of Siena, led by Professor Maurizio Botta, an Adjunct Professor at SHRO, took part to this research.

Nature Clinical Practice Cardiovascular Medicine: September, 2008, Vol.8, No.9

Stem cell niches as clinical targets: the future of anti-ischemic therapy? Editorial on possible clinical impact of research  conducted by an international collaboration of  scientists directed by Sbarro Institute Professor Claudio Napoli, M.D., Ph.D.

Sbarro Institute Professor Claudio Napoli, M.D., Ph.D. Directs International Collaboration on Therapeutic Targeting of the Stem Cell Niche in Experimental Hindlimb Ischemia published in Nature Clinical Practice Cardiovascular Medicine

CNN I-Report Blog: August 14, 2008

Report on tour of  Biomedical Research Labs Island in the company of Prof. Giuseppe Russo (sl name Alfa Roux) , the owner of the sim and CEO of Digi S Lab

SHRO Scores on Second Life: Linden Labs Cites SHRO Platform as Model for Other Health and Wellness Nonprofit Organizations


NewsWise| CNN Blog: Jan 11, 2008

SHRO Opens Internet Center on Futuristic Second Life

 

SHRO Release: October 21, 2008

Developmental Biologist Gianfranco Bellipanni, Ph.D. Joins  Faculty of the Sbarro Intstitute.

 

International Team Reveals First Prognosticator of Survival in Aggressive Cancer

Summer Science at Sbarro Institute:  International program mentors college and high school students for 15th year

Anna Rita Fioroni, Senator of the Democratic Party (PD) in Italy, recently paid a visit to the Sbarro Health Research Organization (SHRO) in Philadelphia

SHRO Release
SHRO Fellow Mario Federico, M.D., publishes chapter on brachytherapy in Principles and Practice of Radiation Oncology, the most widely used textbook on radiation oncology.

SHRO Release | NewsWise: June 25, 2008

Protein Cdk9-55 May Induce Muscle Regeneration in Damaged and Healthy Tissues

Journal of Cellular Physiology: June 10, 2008

Cdk9-55: A New Player in Muscle Regeneration

SHRO Release: Mar 20, 2008

Professor Claudio Napoli: Novel Approach May Spell Safer Gene Therapy

SHRO Release: Jan 11, 2008
The Sbarro Health Research Organization, a nonprofit research group, will open its Internet headquarters on Second Life.


SHRO RELEASE 2007

SHRO Announcement: Nov 12, 2007
"Langfitt International Fellowships" Established with Funds from the Robert R. Bellamy Memorial Foundation and the Thomas and Carolyn Langfitt Family Foundation.

SHRO Photo Release: July 7, 2007
Antonio Giordano Appears on Comcast Newsmakers to Discuss Cancer Research and Expanding Biotech Sciences in the Philadelphia Region.

SHRO Photo Release: May 18, 2007
Pennsylvania House Speaker John Perzel and Committee Chairman Mario Civera, Jr. Join Ceremony for the new Translational Drug.

SHRO Release: May 15, 2007
Cristina Giacinti, MD, Ph.D., wins the "Borsa Monroy" Fellowship to attend "Embryology: Concepts and Techniques in Modern Developmental Biology" at the Marine Biological Laboratory (MBL) in Woods Hole, MA.

SHRO Release: Feb 28, 2007
Laszlo Otvos, M.D., Ph.D., M.B.A., Director of drug development for Sbarro Institute, publishes one of the "Most Cited Articles: 2006."

SHRO Release: Feb 21, 2007
SHRO joins Roche Diagnostics in an on-site agreement that will provide supplies to researchers at SHRO labs.

SHRO Release: Feb 8, 2007
SHRO Labs Ranked Near Top in Research Publications by the Cell Cycle Lab Registry.

SHRO Announcement: Feb 5, 2007
Antonio Giordano receives the 2007 Saint Valentine Prize in Terni, Italy.

SHRO Announcement: Jan 1, 2007
SHRO Announces Competition for Summer Fellowship in Cancer Research in Siena, Italy.


SHRO RELEASE 2006

SHRO Exhibit Announcement: Oct 17, 2006
Sbarro Health Research Organization and Human Health Foundation Exhibit at COM-PA, Milan 21-23 October 2008 (The European Exhibition of Public Communication and Services to Citizen and Business)

SHRO Press Release: Sept 4, 2006
SHRO President Donates Funds to Aid Casa di Riposo Italiana in Uruguay.

SHRO Photo Release: Sept 3, 2006
Fundraiser for SHRO at Positano Coast Restaurant honors Vicent Papale, former Eagles football player and inspiration for hit movie 'Invincible'.

SHRO Release: June 6, 2006
Congressman John Murtha joins officials of Temple's Sbarro Health Research Organization and Windber Research Institute to Announce Pilot Project in Breast Cancer Research.

SHRO Release: April 7, 2006
Sbarro Health Institute and Temple University partner with Italian Trade Commission at BIO 2006 to celebrate renaissance of Italian biotechnology.

SHRO Release: Jan 18, 2007
Eva Surmacz awarded W.W. Smith Grant to examine link between Breast Cancer and Obesity.


SHRO RELEASE 2005

SHRO Announcement: Nov 15, 2005
The Real Deal: Funding Strategies for Early Stage Biotechnology Companies: SHRO co-sponsors a half-day conference on the funding environment for the biotechnology industry."

SHRO Photo Release: Oct 15, 2005
La Famiglia Ristorante Hosts Fundraiser for Sbarro Health Research Organization.

SHRO Release: Jul 14, 2005
Epigenetic activity silences Rb2/p130 gene in lung cancer and retinoblastoma cells "Simple test could be developed to determine cancerous or pre-cancerous conditions".

SHRO Announcement: June 9, 2005
The National Organization of Italian Women honors Dr. Antonio Giordano: "The NOIAW presented a Special Recognition Award to Antonio Giordano, M.D., Ph.D., the Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University."



 

TOP   |    CONTACT   |    SALUTE-PRESS   |    DONATE   |    LINKS


© Copyright 2003 - 2010, Sbarro Health Research Organization,All rights reserved.


download film. video game